Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15623621 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: RAD001 (everolimus)

Indicates status has not been verified in more than two years